Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Use of active surveillance cultures to control vancomycin-resistant Enterococcus.

Diekema DJ.

Clin Infect Dis. 2003 Nov 15;37(10):1400-2; author reply 1402-3. No abstract available.

PMID:
14583882
2.

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.

Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB.

Am J Infect Control. 2007 Mar;35(2):73-85.

PMID:
17327185
3.

Vancomycin-resistant enterococci in the pediatric patient.

Bratcher DF.

Pediatr Infect Dis J. 2001 Jun;20(6):621-2. Review. No abstract available.

PMID:
11419507
4.

For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?

Farr BM.

Clin Infect Dis. 2004 Apr 15;38(8):1116-8. Epub 2004 Apr 5. No abstract available.

PMID:
15095216
5.

Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.

Edmond M.

Infect Control Hosp Epidemiol. 2003 May;24(5):309-10; author reply 310-2. No abstract available.

PMID:
12785400
6.

Infection control can help keep VRE in check.

Steele T.

Nephrol News Issues. 1999 May;13(5):37. No abstract available.

PMID:
10578822
7.

Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.

Division of Nosocomial and Occupationl Infectious Diseases, Bureau of Infectious Diseases, Laboratory Centre for Disease Control, Health Canada; VRE Working Group, Canadian Hospital Epidemiology Committee.

Can Commun Dis Rep. 1997 Dec;23 Suppl 8:i-iv, 1-16, i-iv, 1-19. English, French. No abstract available.

8.

Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.

Cheng AC, Harrington G, Russo P, Liolios L, Spelman D.

Intern Med J. 2004 Aug;34(8):510-2.

PMID:
15317552
9.

VRE. How you can stop the spread of this drug-resistant organism.

Cooper E.

RN. 2008 Feb;71(2):27-31; quiz 32. Review. No abstract available.

PMID:
18386441
10.

Control of nosocomial acquisition of vancomycin-resistant Enterococcus through active surveillance of hemodialysis patients.

Axon RN, Engemann JJ, Butcher J, Lockamy K, Kaye KS.

Infect Control Hosp Epidemiol. 2004 May;25(5):436-8.

PMID:
15188852
12.

Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.

Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG Jr, Smith DL.

Clin Infect Dis. 2004 Apr 15;38(8):1108-15. Epub 2004 Apr 5.

PMID:
15095215
13.

Vancomycin-resistant enterococci (VRE): transmission and control.

Tacconelli E, Cataldo MA.

Int J Antimicrob Agents. 2008 Feb;31(2):99-106. doi: 10.1016/j.ijantimicag.2007.08.026. Epub 2007 Dec 31. Review.

PMID:
18164908
14.

Guidelines for the control of glycopeptide-resistant enterococci in hospitals.

Cookson BD, Macrae MB, Barrett SP, Brown DF, Chadwick C, French GL, Hateley P, Hosein IK, Wade JJ; Combined Working Party of the Hospital Infection Society and Infection Control Nurses Association.

J Hosp Infect. 2006 Jan;62(1):6-21. Epub 2005 Nov 28.

PMID:
16310890
15.

Understanding VRE is key to prevention.

Oriola S.

Mater Manag Health Care. 2009 May;18(5):34-6. No abstract available.

PMID:
19771773
16.

Vancomycin-resistant enterococcus: a review from a Singapore perspective.

Chlebicki MP, Kurup A.

Ann Acad Med Singapore. 2008 Oct;37(10):861-9. Review.

17.

Controlling VRE.

Jacobson AF, Winslow EH.

Am J Nurs. 1999 Jun;99(6):68. No abstract available.

PMID:
10489565
18.

Protecting long-term care patients from antibiotic resistant infections: ethics, cost-effectiveness, and reimbursement issues.

Farr BM.

J Am Geriatr Soc. 2000 Oct;48(10):1340-2. Review. No abstract available.

PMID:
11037026
19.

Clinical correlates of vancomycin-resistant enterococci/meticillin-resistant Staphylococcus aureus co-colonization and co-infection in Singapore.

Kurup A, Wong YY, Tan KY, Low JG.

J Hosp Infect. 2008 Nov;70(3):291-2. doi: 10.1016/j.jhin.2008.08.001. No abstract available.

PMID:
18804897
20.

Arresting drug-resistant organisms.

Kjonegaard R, Myers FE 3rd.

Nursing. 2005 Jun;35(6):48-50. No abstract available.

PMID:
15931121

Supplemental Content

Support Center